Mylan is the third-largest generic pharmaceutical company in the world. We hold top-five positions in 13 different established markets worldwide and are building a strong presence in many emerging generics markets.

Today, we market more than 570 products to consumers in more than 140 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products. We also have the deepest pipeline and largest number of products pending regulatory approval in company history.

At Mylan, we are always ready to meet the challenges of the dynamic global pharmaceutical industry with its numerous and wide-ranging issues – from complex research, development and regulatory conditions to rapidly changing consumer demands.

Whether we’re improving the health of patients worldwide or meeting the diverse needs of our customers, Mylan delivers. Every time, all the time.